Document is current
Any future updates will be listed below
-
Authors
Dennis, Michael J. https://orcid.org/0000-0002-8175-5311
Pavlick, Dean C.
Kacew, Alec
Wotman, Michael
MacConaill, Laura E.
Jones, Stephanie M.
Pfaff, Kathleen L.
Rodig, Scott J.
Eacker, Stephen
Malig, Maika
Reister, Emily
Piccioni, David
Kesari, Santosh
Sehgal, Kartik
Haddad, Robert I.
Cohen, Ezra
Posner, Marshall R.
Deichaite, Ida
Hanna, Glenn J.
- License Information
-
More Information
Article History
Received: 12 September 2024
Accepted: 10 October 2024
First Online: 22 October 2024
Declarations
:
: The Institutional Review Boards at Dana-Farber/Harvard Cancer Centers, MSH, UCSD, and the Western Institutional Review Board (Institutional Review Board for FMI) reviewed and approved the study protocol. This study was conducted in accordance with the Declaration of Helsinki and the requirements of the Code of Federal Regulations on the Protection of Human Subjects (45 CFR 46), including its relevant Subparts, for federally funded/support research studies. It was determined that a waiver of informed consent was granted for historic subjects (both clinical and research) as it meets the requirements outlined in45 CFR 46.116(f).
: Not applicable.
: DCP is an employee of Foundation Medicine, Inc (FMI) and owns equity interest in F. Hoffmann-La Roche AG, of which FMI is a wholly-owned subsidiary. All other authors declare that they have no competing interests.
